The Effect of Thiazolidinediones and SGLT-2 Inhibitors on Minerals,VIT.D3, Blood Glucose and Weight Gain in Wistar Rats Induced with Type 2 Diabetes | [Pakistan Journal of Medical and Health Sciences • 2022]

Author(s):

1. SHAIMAA ADNAN ABD ALHUSSIEN ALSHMMARI: Biology Faculty of Science-University of Kufa

2. SUAAD MOHAMMAD JODA AL-HADRAWY: Faculty of Sciences, Department of Biology University of Kufa,

Abstract:

Type 2 diabetes mellitus and osteoporosis are among the most common health problems around the world. Diabetes is usually associated with increase a risk of bone fracture, Recent studies has indicated the harmful effects of some of anti-diabetic drugs on bone metabolism. Therefore, the goal of this study was to investigate the effect of two types of anti-diabetic drugs: Thiazolidinediones (TZDs) (30 mg/kg) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors (10 mg/kg) on Vit.D and bone minerals on serum of laboratory female rats induced with type 2 diabetes mellitus. The study was conducted on animals Faculty of science/ Department of biology/University of kufa. And Central Laboratories / In Medical City. during the period from 27 october 2021 till the end of 22 February 2022. Thirty-two adults female Albino rats (Rattus norvigicus) were randomly divided to two main groups of sixteen animals, The first group was treated for a period of 2 weeks and the second group was treated for a period of 2 months. Each group of them was divided into secondary four groups of four rats including: a control (Co1 and Co2) were fed regular rats pellet, the second group (HFD 1 and HFD 2) were fed with high fat diet (42% lipid, 32%g sucrose, 14% protein), the third group were fed with high fat diet and treated with TZDs (30 mg/kg) and fourth group were fed with high fat diet and treated with SGLT-2i (10 mg/kg). After the end of the treatment period, which is two weeks and three months, the blood was drawn using a method of cardiac puncture technique for estimation of blood glucose, bone minerals in serum which include (calcium, magnesium, inorganic phosphate) and serum Vit.D3 concentration. Body weight gain was significantly increased (p=0.05) in animals treated with HFD high-fat diet (uncontrolled diabetic group) and in animals treated with TZDs compared to the control and animals treated with SGLT-2i. Also, the results of this study showing a significant increase (p£0.05) on blood glucose in animals fed with HFD compared with other groups and there was a significant decrease (p£0.05) in blood glucose in animals group treated with TZDs and SGLT-2i compared with HFD. The diabetic induced group (HFD group) treated for two months showed a significant decrease (p=0.05) in vitamin D3 concentrations. The results of calcium concentrations in the blood showed a significant decrease (p=0.05) in calcium concentration in the group induced with diabetes and the group treated with TZDs for two months compared to other groups. With regard to magnesium concentrations, the results showed a significant decrease (p=0.05) in the group induced with diabetes and the group treated with TZDs for two months compared to other groups. While there was a significant increase (p=0.05) in the concentrations of magnesium in the group treated with SGLT2i for two months compared to other groups. Also, the results showed a significant increase in the concentrations of serum inorganic phosphate in the groups treated with high-fat diet (diabetic induced group) for two months and the group treated with SGLT2i for two months, compared to the control group and the groups treated with TZDs. In conclusion: Uncontrolled diabetes mellitus has adverse effects on the concentrations of Vit.D3 and bone minerals. Also, Long-term treatment with Thiazolidinedionse (TZDs) and SGLT-2 inhibitors, despite its control of blood sugar has harmful effects on bone minerals and Vit.D3.

Page(s): 407-412

DOI: 10.53350/pjmhs22166407

Published: Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Keywords:

T2DM , Magnesium , Calcium , Thiazolidinediones , SGLT2 inhibitor , Vit D3 , Inorganic phosphate

References:

[1] Ckuliak P,AKužma M,J M .2019 .Effect of antidiabetic treatment on bone. Physiol Res, 68 : .

[2] Bae J,Park T,Kim H,Lee M,Cha BS,Tsagareli M,Giorgadze E,Khachidze N,Dolidze N,Sulikashvili T,Jeiranashvili N.,6TH FLOOR .2019 .LONDON WC1X 8HL. In: OSTEOPOROSIS INTERNATIONAL. Vol 30. SPRINGER LONDON LTD 236 GRAYS INN RD, 0272(3) : S314-S314.

[3] Pavlova V,Filipova E,Uzunova K,Kalinov K,Vekov T.,Endocrine T.,Metab Immune Disord Targets (Formerly Curr Drug Targets-Immune T. .2018 .Pioglitazone therapy and fractures: systematic review and meta-analysis.. Endocr Metab Disord, 18(5) : 502-507.

[4] Urbanovych A,Kryvko O.,Steen O,Goldenberg RM .2017 .The role of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes. Can J diabetes, 41(5) : 517-523.

[5] DeFronzo RA,Davidson JA,Del Prato S. .2012 .The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes, Obes Metab, 14(1) : 5-14.

[6] Bilezikian JP,Watts NB,Usiskin K .2016 .Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol, 101(1) : 44-51.

[7] Lotfy M,Adeghate J,Kalasz H,Singh J,Adeghate E .2017 .Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev, 13(1) : 3-10.

[8] Kolluru GK,Bir SC,Kevil CG .2012 .Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med, : .

[9] Patel O,Muller CJF,Joubert E,Rosenkranz B,Louw J,Awortwe C,Mabilleau G,Bouvard B. .2020 .Update on: effects of anti-diabetic drugs on bone metabolism. Expert Rev Endocrinol Metab, 15(6) : 415-430.

[10] Blau JE,Rother KI .2015 .Possible adverse effects of SGLT2 inhibitors on bone. lancet Diabetes Endocrinol, 3(1) : 8-10.

[11] Barbosa-Da-Silva S,Isabele ;,Sarmento B .2014 .. Animal Models of Nutritional Induction of Type 2 Diabetes Mellitus Modelos Animales de Inducción Nutricional Para Diabetes Mellitus Tipo 2, : .

[12] Okemah J,O'Neil PM J .2019 .Body Weight Considerations in the Management of Type 2 Diabetes. Adv Ther, 36(1) : 44-58.

[13] Lang P,Hasselwander S,Li H,Xia N. .2019 .Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice. Sci Rep, 9(1) : 1-14.

[14] . .Applying recent A1C recommendations in clinical practice. doi:10, : .

[15] Pharm US .2018 .. , 43(10) : 15-22.

[16] Ribola FA,Cançado FB,Schoueri JHM,De Toni VF,Medeiros VHR,Feder D. .2020 .Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci., 10(6) : 346-353.

[17] Sanches CP,Vianna AGD,Barreto FDC .2017 .The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr, 9(1) : 1-7.

[18] .2011 .. doi:10.1186/s13098-017-0278-1 Division D. Original Article การเปร ี ยบเท ี ยบการซ ี มผ ี านแผ ี นก ี ีนผ ี วหน ี งคนก ี บหม ี ในหลอดทดลอง ของสารพอล ี ฟ ี นอลจากพ ี ช บทค ี ดย ี อ. Bangladesh J Med Sci, 4(1) : 10-19.

[19] Pritchard JM,Papaioannou A,Tomowich C .2013 .Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone, 54(1) : 76-82.

[20] Zhang Q,Wu Y,Fei X .2016 .Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina (B Aires), 52(1) : 28-34.

[21] Romero-Díaz C,Duarte-Montero D,Gutiérrez-Romero SA,Mendivil CO .2021 .. Diabetes and Bone Fragility. Diabetes Ther, 12(1) : 71-86.

Citations

Downloads

Views